تخطي إلى التنقل الرئيسي
تخطي إلى البحث
تخطي إلى المحتوى الرئيسي
فرز حسب
Keyphrases
Small Molecules
100%
Meta-analysis
100%
Ulcerative Colitis
100%
Maintenance Performance
100%
Biological Agents
100%
Efficacy Safety
100%
Moderate to Severe
75%
Cumulative Ranking
75%
Severe Ulcerative Colitis
75%
Maintenance Treatment
50%
Infliximab
50%
Comparative Efficacy
50%
Upadacitinib
50%
Tofacitinib
50%
Etrasimod
50%
Comparative Safety
50%
Therapeutic Profile
50%
Hierarchical Analysis
25%
MEDLINE
25%
Embase
25%
Cochrane Library
25%
Maintenance Therapy
25%
Clinical Remission
25%
Armamentarium
25%
Safety Profile
25%
Derandomization
25%
Safety Performance
25%
Ranking Values
25%
Library Databases
25%
Bayesian Network
25%
Induction Period
25%
Emerging Treatments
25%
Pharmacology, Toxicology and Pharmaceutical Science
Ulcerative Colitis
100%
Randomized Controlled Trial
75%
Infliximab
50%
Upadacitinib
50%
Tofacitinib
50%
Etrasimod
50%
Remission
25%
Immunology and Microbiology
Ulcerative Colitis
100%
Infliximab
50%
Etrasimod
50%
Tofacitinib
50%
Medline
25%
Cochrane Library
25%